Publication:
Relationship between plasma interleukin-12 (IL-12) and IL-18 levels and severe malarial anemia in an area of holoendemicity in western Kenya

dc.contributor.authorSujittra Chaisavaneeyakornen_US
dc.contributor.authorCaroline Othoroen_US
dc.contributor.authorYa Ping Shien_US
dc.contributor.authorJuliana Otienoen_US
dc.contributor.authorSansanee C. Chaiyarojen_US
dc.contributor.authorAltaf A. Lalen_US
dc.contributor.authorVenkatachalam Udhayakumaren_US
dc.contributor.otherNational Center for Infectious Diseasesen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherKenya Medical Research Instituteen_US
dc.contributor.otherNew Nyanza Provincial General Hospitalen_US
dc.contributor.otherCenters for Disease Control and Preventionen_US
dc.date.accessioned2018-07-24T03:19:49Z
dc.date.available2018-07-24T03:19:49Z
dc.date.issued2003-06-01en_US
dc.description.abstractIn this study, we investigated whether levels of interleukin-12 (IL-12) and IL-18 in plasma are associated with severe malarial anemia outcomes in an area of holoendemicity in western Kenya. We compared plasma IL-12 and IL-18 levels in six groups of children grouped into the categories aparasitemic, asymptomatic, mild malaria, high-density uncomplicated malaria (UC), moderate malarial anemia (MMA), or severe malarial anemia (SMA). IL-12 levels were significantly reduced in children with SMA (P < 0.05) but not in other groups compared to children in the aparasitemic control group. IL-18, a cytokine known to be critical for the induction of gamma interferon along with IL-12, was produced more frequently (70%) in children with UC (P = 0.06) than in children in the aparasitemic control group (32%). However, in the SMA group the IL-18 response rate declined to 30%, which was similar to that in the aparasitemic control group, which showed a 32% response rate. This finding suggests that the IL-18 response may be impaired in children with SMA. In summary, the results from this study support the hypothesis that impairment of IL-12 and/or IL-18 response may contribute to the development of severe malarial anemia in areas of holoendemicity for malaria.en_US
dc.identifier.citationClinical and Diagnostic Laboratory Immunology. Vol.10, No.3 (2003), 362-366en_US
dc.identifier.doi10.1128/CDLI.10.3.362-366.2003en_US
dc.identifier.issn1071412Xen_US
dc.identifier.other2-s2.0-0038633500en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/20724
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0038633500&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.titleRelationship between plasma interleukin-12 (IL-12) and IL-18 levels and severe malarial anemia in an area of holoendemicity in western Kenyaen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0038633500&origin=inwarden_US

Files

Collections